SMARCAL1 is a new osteosarcoma predisposition gene.

Saved in:
Bibliographic Details
Title: SMARCAL1 is a new osteosarcoma predisposition gene.
Authors: Rafati M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States., Guenther LM; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN 38105, United States., Egolf LE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, United States., Gianferante M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States., Kim J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States., Wang K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States., Zhu B; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States., Spector LG; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55454, United States., Anderson N; Department of Pediatrics, University of Minnesota, Minneapolis, MN 55454, United States., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA 02215, United States., Barkauskas DA; Department of Population and Public Health Sciences, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90032, United States., Hawkins DS; Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA 98105, United States., Patiño-Garcia A; Department of Pediatrics/Medical Genomics Unit and Program in Solid Tumors, Cima-Universidad de Navarra, Cancer Center Clínica Universidad de Navarra Pamplona, IdiSNA, Pamplona 31008, Spain., Lupo PJ; Research and Epidemiology for Adolescent and Child Health (REACH) Center, Children's Healthcare of Atlanta, Atlanta, GA 30322, United States.; Department of Pediatrics, School of Medicine, Emory University, Atlanta, GA 30322, United States.; Division of Hematology and Oncology, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, United States., Scheurer ME; Research and Epidemiology for Adolescent and Child Health (REACH) Center, Children's Healthcare of Atlanta, Atlanta, GA 30322, United States.; Department of Pediatrics, School of Medicine, Emory University, Atlanta, GA 30322, United States.; Division of Hematology and Oncology, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, United States., Morton L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States., Armstrong GT; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN 38105, United States., Sapkota Y; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN 38105, United States., Gramatges MM; Division of Hematology and Oncology, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, United States., Serra M; Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Ortopedico Rizzoli, Bologna 40136, Italy., Hattinger C; Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Ortopedico Rizzoli, Bologna 40136, Italy., Scotlandi K; Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna 40136, Italy., Andrulis IL; Department of Molecular Genetics, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, University of Toronto, Toronto, ON M5G 1X5, Canada., Wunder JS; University of Toronto Musculoskeletal Oncology Unit, Sinai Health System, Toronto, ON M5G 1X5, Canada., Ballinger ML; Centre for Molecular Oncology, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia., Thomas DM; Centre for Molecular Oncology, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia., Yeager M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, United States., Dean M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States., Stewart DR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States., Vogt A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, United States., Liu J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, United States., Hicks BD; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, United States., Huang WY; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States., Landi MT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States., Lori A; Department of Population Science, American Cancer Society, Atlanta, GA 30303, United States., Diver WR; Department of Population Science, American Cancer Society, Atlanta, GA 30303, United States., Savage SA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States., Mirabello L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850-9772, United States.
Source: Journal of the National Cancer Institute [J Natl Cancer Inst] 2026 Jun 01; Vol. 118 (6), pp. 1120-1125.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1460-2105
DOI:10.1093/jnci/djaf278